Works matching IS 03125963 AND DT 2014 AND VI 53 AND IP 10
Results: 9
Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 919, doi. 10.1007/s40262-014-0163-0
- By:
- Publication type:
- Article
Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 931, doi. 10.1007/s40262-014-0166-x
- By:
- Publication type:
- Article
Pharmacokinetic Enhancers in HIV Therapeutics.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 865, doi. 10.1007/s40262-014-0167-9
- By:
- Publication type:
- Article
Population Pharmacokinetics of Rabeprazole and Dosing Recommendations for the Treatment of Gastroesophageal Reflux Disease in Children Aged 1-11 Years.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 943, doi. 10.1007/s40262-014-0168-8
- By:
- Publication type:
- Article
Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 873, doi. 10.1007/s40262-014-0170-1
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous System.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 891, doi. 10.1007/s40262-014-0171-0
- By:
- Publication type:
- Article
Erratum to: Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition.
- Published in:
- 2014
- By:
- Publication type:
- Correction Notice
Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers: Integrated Analysis of Intravenous and Subcutaneous, Single- and Multiple-Dose Administration.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 10, p. 907, doi. 10.1007/s40262-014-0159-9
- By:
- Publication type:
- Article